Entry Detail



General Information

Database ID:exR0076853
RNA Name:MIF
RNA Type:mRNA
Chromosome:chr22
Starnd:+
Coordinate:
Start Site(bp):23894383End Site(bp):23895227
External Links:ENSG00000240972



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AIF1L
chr9
131096476
131123152
+
AC120057.2
chr17
7240427
7244635
-
AL139300.1
chr14
103562962
103685924
+
AHNAK
chr11
62433542
62556235
-
AIMP2
chr7
6009255
6023834
+
AC024592.3
chr19
5866171
5903787
-
AL121594.1
chr14
35122549
35317474
+
ACTR1B
chr2
97655939
97664044
-
ALDH1L1
chr3
126103562
126197994
-
ABCF1
chr6
30571393
30597179
+
AC007192.1
chr19
18153158
18178117
+
ABRACL
chr6
139028745
139043302
+
AHCY
chr20
34280268
34311802
-
AL645941.2
chr6
32937364
32953122
-
ALDH3A2
chr17
19648136
19685760
+
ACAP3
chr1
1292390
1309609
-
AC091167.2
chr15
90249556
90272208
+
AC010422.3
chr19
12643831
12648397
-
ABCD3
chr1
94418389
94518666
+
AC131160.1
chr3
183815568
183884889
-
AC010132.3
chr7
42909273
42932174
-
AL365205.1
chr6
41780349
41790141
+
ACTB
chr7
5527148
5563784
-
ALDH9A1
chr1
165662216
165698863
-
AC040162.1
chr16
67929614
67936017
-
AAAS
chr12
53307456
53324864
-
AIDA
chr1
222668013
222713210
-
AKR7A2
chr1
19303965
19312146
-
ACTR2
chr2
65227753
65271253
+
ACAP1
chr17
7336529
7351477
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-320a-3p
chr8
22244975
22244996
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004241.1
chr12
47706083
47742294
+
AC016876.2
chr17
7581964
7584086
-
AC023790.2
chr12
13000451
13040679
+
AC026362.1
chr12
122975320
122982907
+
AC051619.7
chr15
45200325
45200632
-
AC108134.2
chr16
3156736
3157483
-
AC245014.3
chr1
145281116
145281462
+
AL022311.1
chr22
37876148
37895563
+
AL121992.1
chr1
15586136
15603626
-
AL137782.1
chr13
75549773
75807120
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA